Sign inGet started

F2 MG Ltd

Insider CIK 1767396 · TCRR 10% owner · CGEM 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-14503,988— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-141,282,051— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-141,007,977— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-14503,988— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-141,511,966— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-148,000,000— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-1420,500,000— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-143,205,128— $00SEC↗
CGEM Cullinan Management, Inc. C Conversion deriv2021-01-122021-01-144,500,000— $00SEC↗
CGEM Cullinan Management, Inc. P Buy2021-01-122021-01-1495,238$21.00 $2.00M622,175SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-14214,798— $0214,798SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-1471,599— $071,599SEC↗
CGEM Cullinan Management, Inc. P Buy2021-01-122021-01-14104,762$21.00 $2.20M104,762SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-14143,198— $0325,333SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-1471,599— $0526,937SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-14182,135— $0182,135SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-14455,338— $0455,338SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-14639,295— $0639,295SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-142,912,345— $02,912,345SEC↗
CGEM Cullinan Management, Inc. C Conversion2021-01-122021-01-141,136,525— $01,136,525SEC↗
TCRR TCR2 THERAPEUTICS INC. J Other2019-12-202019-12-2013,847— $0161,024SEC↗
TCRR TCR2 THERAPEUTICS INC. J Other2019-12-202019-12-20586,153— $0713,723SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-192019-12-206,642$16.47 $109.4K82,575SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-192019-12-2035,323$16.47 $581.8K155,986SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-182019-12-202,433$17.01 $41.4K191,309SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-182019-12-20458$17.01 $7.8K89,217SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-112019-12-114,153$17.65 $73.3K1,299,876SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-112019-12-111,054$17.65 $18.6K330,238SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-112019-12-111,381$17.65 $24.4K432,319SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-112019-12-111,155$17.65 $20.4K361,665SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-102019-12-1130,475$17.62 $537.0K1,304,029SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-102019-12-117,741$17.62 $136.4K331,292SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-102019-12-1110,135$17.62 $178.6K433,700SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-102019-12-118,479$17.62 $149.4K362,820SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-092019-12-1175,067$17.65 $1.32M1,334,504SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-092019-12-1119,070$17.65 $336.6K339,033SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-092019-12-1124,966$17.65 $440.6K443,835SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-12-092019-12-1120,886$17.65 $368.6K371,299SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-10-222019-10-24580$15.16 $8.8K392,185SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-10-222019-10-24693$15.16 $10.5K392,185SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-10-222019-10-24530$15.16 $8.0K358,103SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-10-222019-10-242,085$15.16 $31.6K1,409,571SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-245,516$17.31 $95.5K1,411,656SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-24683$17.31 $11.8K174,871SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-24351$17.31 $6.1K89,675SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-241,835$17.31 $31.8K469,464SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-241,401$17.31 $24.3K358,633SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-232019-09-241,535$17.31 $26.6K392,765SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-2450,134$17.94 $899.4K360,034SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-2424,446$17.94 $438.6K175,554SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-2465,633$17.94 $1.18M471,299SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-24197,343$17.94 $3.54M1,417,172SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-2412,537$17.94 $224.9K90,026SEC↗
TCRR TCR2 THERAPEUTICS INC. S Sale2019-09-202019-09-2454,907$17.94 $985.0K394,300SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion deriv2019-02-192019-02-212,500,000— $00SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion deriv2019-02-192019-02-2110,000,001— $00SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion deriv2019-02-192019-02-211,200,000— $00SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion deriv2019-02-192019-02-212,540,500— $00SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion deriv2019-02-192019-02-211,750,000— $00SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion2019-02-192019-02-21193,742— $0193,742SEC↗
TCRR TCR2 THERAPEUTICS INC. P Buy2019-02-192019-02-21166,667$15.00 $2.50M449,207SEC↗
TCRR TCR2 THERAPEUTICS INC. P Buy2019-02-192019-02-21133,333$15.00 $2.00M536,962SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion2019-02-192019-02-211,614,515— $01,614,515SEC↗
TCRR TCR2 THERAPEUTICS INC. P Buy2019-02-192019-02-21166,667$15.00 $2.50M166,667SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion2019-02-192019-02-21410,168— $0410,168SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion2019-02-192019-02-21282,540— $0282,540SEC↗
TCRR TCR2 THERAPEUTICS INC. C Conversion2019-02-192019-02-21403,629— $0403,629SEC↗
TCRR TCR2 THERAPEUTICS INC. P Buy2019-02-192019-02-21200,000$15.00 $3.00M200,000SEC↗